111 related articles for article (PubMed ID: 37247894)
1. Overexpression of
Hippner-Kunicka M; Laszkiewicz A; Skrzymowska J; Biecek P; Donizy P; Miazek A
Anticancer Res; 2023 Jun; 43(6):2527-2538. PubMed ID: 37247894
[TBL] [Abstract][Full Text] [Related]
2. ENO1 gene product binds to the c-myc promoter and acts as a transcriptional repressor: relationship with Myc promoter-binding protein 1 (MBP-1).
Feo S; Arcuri D; Piddini E; Passantino R; Giallongo A
FEBS Lett; 2000 May; 473(1):47-52. PubMed ID: 10802057
[TBL] [Abstract][Full Text] [Related]
3. α-Enolase inhibits apoptosis and promotes cell invasion and proliferation of skin cutaneous melanoma.
Zhang K; Tian R; Zhang W; Li Y; Zeng N; Liang Y; Tang S
Mol Biol Rep; 2022 Sep; 49(9):8241-8250. PubMed ID: 35925486
[TBL] [Abstract][Full Text] [Related]
4. The kelch protein NS1-BP interacts with alpha-enolase/MBP-1 and is involved in c-Myc gene transcriptional control.
Perconti G; Ferro A; Amato F; Rubino P; Randazzo D; Wolff T; Feo S; Giallongo A
Biochim Biophys Acta; 2007 Dec; 1773(12):1774-85. PubMed ID: 17996313
[TBL] [Abstract][Full Text] [Related]
5. c-myc promoter binding protein regulates the cellular response to an altered glucose concentration.
Sedoris KC; Thomas SD; Miller DM
Biochemistry; 2007 Jul; 46(29):8659-68. PubMed ID: 17595061
[TBL] [Abstract][Full Text] [Related]
6. Expression of Alpha-Enolase (ENO1), Myc Promoter-Binding Protein-1 (MBP-1) and Matrix Metalloproteinases (MMP-2 and MMP-9) Reflect the Nature and Aggressiveness of Breast Tumors.
Cancemi P; Buttacavoli M; Roz E; Feo S
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31416219
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia induces differential translation of enolase/MBP-1.
Sedoris KC; Thomas SD; Miller DM
BMC Cancer; 2010 Apr; 10():157. PubMed ID: 20412594
[TBL] [Abstract][Full Text] [Related]
8. The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity.
Hsu KW; Hsieh RH; Lee YH; Chao CH; Wu KJ; Tseng MJ; Yeh TS
Mol Cell Biol; 2008 Aug; 28(15):4829-42. PubMed ID: 18490439
[TBL] [Abstract][Full Text] [Related]
9. Separate domains of MBP-1 involved in c-myc promoter binding and growth suppressive activity.
Ray RB; Steele R
Gene; 1997 Feb; 186(2):175-80. PubMed ID: 9074493
[TBL] [Abstract][Full Text] [Related]
10. MBP-1 is efficiently encoded by an alternative transcript of the ENO1 gene but post-translationally regulated by proteasome-dependent protein turnover.
Lung J; Liu KJ; Chang JY; Leu SJ; Shih NY
FEBS J; 2010 Oct; 277(20):4308-21. PubMed ID: 20849415
[TBL] [Abstract][Full Text] [Related]
11. Myc promoter-binding protein-1 (MBP-1) is a novel potential prognostic marker in invasive ductal breast carcinoma.
Lo Presti M; Ferro A; Contino F; Mazzarella C; Sbacchi S; Roz E; Lupo C; Perconti G; Giallongo A; Migliorini P; Marrazzo A; Feo S
PLoS One; 2010 Sep; 5(9):e12961. PubMed ID: 20886042
[TBL] [Abstract][Full Text] [Related]
12. New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.
Gottfried E; Lang SA; Renner K; Bosserhoff A; Gronwald W; Rehli M; Einhell S; Gedig I; Singer K; Seilbeck A; Mackensen A; Grauer O; Hau P; Dettmer K; Andreesen R; Oefner PJ; Kreutz M
PLoS One; 2013; 8(7):e66987. PubMed ID: 23874405
[TBL] [Abstract][Full Text] [Related]
13. Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death.
Ejeskär K; Krona C; Carén H; Zaibak F; Li L; Martinsson T; Ioannou PA
BMC Cancer; 2005 Dec; 5():161. PubMed ID: 16359544
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid-mediated down-regulation of ENO1/MBP-1 gene products caused decreased invasiveness of the follicular thyroid carcinoma cell lines.
Trojanowicz B; Winkler A; Hammje K; Chen Z; Sekulla C; Glanz D; Schmutzler C; Mentrup B; Hombach-Klonisch S; Klonisch T; Finke R; Köhrle J; Dralle H; Hoang-Vu C
J Mol Endocrinol; 2009 Mar; 42(3):249-60. PubMed ID: 19060179
[TBL] [Abstract][Full Text] [Related]
15. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
[TBL] [Abstract][Full Text] [Related]
16. A novel 16-kilodalton cellular protein physically interacts with and antagonizes the functional activity of c-myc promoter-binding protein 1.
Ghosh AK; Majumder M; Steele R; White RA; Ray RB
Mol Cell Biol; 2001 Jan; 21(2):655-62. PubMed ID: 11134351
[TBL] [Abstract][Full Text] [Related]
17. [Small interfering RNA-mediated α-enolase knockdown suppresses glycolysis and proliferation of human glioma U251 cells in vitro].
Luo QS; Fu HD; Huang HN; Huang HD; Luo KX; Li CY; Qin CJ; Li XY; Luo HC; Wang JL; Tang QL
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Nov; 37(11):1484-1488. PubMed ID: 29180328
[TBL] [Abstract][Full Text] [Related]
18. Functional domains of c-myc promoter binding protein 1 involved in transcriptional repression and cell growth regulation.
Ghosh AK; Steele R; Ray RB
Mol Cell Biol; 1999 Apr; 19(4):2880-6. PubMed ID: 10082554
[TBL] [Abstract][Full Text] [Related]
19.
Liang X; Lu J; Wu Z; Guo Y; Shen S; Liang J; Dong Z; Guo W
Mol Cancer Res; 2021 Sep; 19(9):1465-1475. PubMed ID: 34016746
[TBL] [Abstract][Full Text] [Related]
20. Resistance to arginine deiminase treatment in melanoma cells is associated with induced argininosuccinate synthetase expression involving c-Myc/HIF-1alpha/Sp4.
Tsai WB; Aiba I; Lee SY; Feun L; Savaraj N; Kuo MT
Mol Cancer Ther; 2009 Dec; 8(12):3223-33. PubMed ID: 19934275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
